The Washington Post: Need reading glasses? Here is your frame of reference
UC professor offers guidance in buying something most will need at some point
Journalist Laura Daily spoke with optometrists, ophthalmologists and industry experts for a consumer story on purchasing glasses. Karl Golnik, chair of the UC Department of Ophthalmology in the College of Medicine explained that most individuals past age 40 need glasses and eventually readers because the lens inside the eye changes over time and loses flexibility.
Golnik told the Post that as long as there is no astigmatism (or it is corrected with contact lenses) and the correction for reading is about the same in each eye, there is no reason not to buy over-the-counter (OTC) models. It doesn’t matter where you get them, be it the grocery store or a rack at your favorite boutique, he noted.
Related Stories
'Time is brain' again, now for control of intracerebral hemorrhage
February 5, 2026
MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).
Children exposed to gambling mechanics before they understand money
February 4, 2026
Gambling-style mechanics are becoming a routine part of children’s digital lives, appearing in online games, mobile apps and even sports betting advertisements that surround popular media. University of Cincinnati experts warned in a recent WKRC-TV Local 12 report that long before children understand the value of money, they are learning the emotional highs and lows associated with risk. Online games, such as Roblox and Fortnite, offer fast-paced rewards that can keep children glued to screens.
Study: Synthetic protein potentially improves outcomes for certain subgroups following intracerebral hemorrhage
February 4, 2026
The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.